Does urethral competence affect urodynamic voiding parameters in women with prolapse? by Nygaard, Ingrid E. et al.
Neurourology and Urodynamics 26:1030–1035 (2007)
Does Urethral Competence Affect Urodynamic
Voiding Parameters in Women With Prolapse?
Ingrid Nygaard,1* Karl Kreder,2 Elizabeth Mueller,3 Linda Brubaker,3 Patricia Goode,4
Anthony Visco,5 Anne M. Weber,6 Geoff Cundiff,7 and John Wei8 for the Pelvic Floor Disorders Network
1Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah
2Department of Urology, University of Iowa Carver College of Medicine, Iowa City, Iowa
3Departments of Urology and Obstetrics and Gynecology, Loyola University Medical Center, Maywood, Illinois
4Birmingham/Atlanta Geriatric Research, Education and Clinical Center, Birmingham Veterans Affairs Medical Center
and Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
5Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
6National Institute for Child Health and Human Development
7Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada
8Department of Urology, University of Michigan, Ann Arbor, Michigan
Aims: To (1) compare voiding parameters and (2) correlate symptoms and urodynamic findings in women with pelvic organ
prolapse (POP) and varying degrees of urethral competence. Methods: We compared three groups of women with stages II–IV POP.
Groups 1 and 2 were symptomatically stress continent women participating in the Colpopexy and Urinary Reduction Efforts (CARE)
trial; during prolapse reduction before sacrocolpopexy, Group 1 (n ¼ 67) did not have and Group 2 (n ¼ 84) had urodynamic stress
incontinence (USI) during prolapse reduction. Group 3 participants (n ¼ 74), recruited specifically for this study, had stress urinary
incontinence (SUI) symptoms and planned sacrocolpopexy. Participants completed standardized uroflowmetry, pressure voiding
studies, and validated symptom questionnaires. Results: Subjects’ median age was 61 years, median parity 3 and 87% had stage III
or IV POP. Fourteen percent of women in Group 3 demonstrated USI without, and 70% with, prolapse reduction. Women in Groups 2
and 3 had more detrusor overactivity (DO) than Group 1 (17 and 24% vs. 6%, P¼ 0.02) and detrusor overactivity incontinence (DOI)
(15 and 8% vs. 0%, P¼ 0.004). Based on the Blaivis–Groutz nomogram, 60% of all women were obstructed. Post-void residual volume
(PVR), peak flow rate, detrusor pressure at peak flow, voiding mechanisms, voiding patterns, obstruction and urinary retention did
not differ among groups. Women in Group 3 had higher irritative and obstructive symptom scores than Group 1 or 2; neither score
differed by presence of DO nor obstruction, respectively. Conclusion: Women with POP have significant rates of urodynamic
obstruction and retention, independent of their continence status. Symptoms of obstruction and retention correlate poorly with
urodynamic findings. Neurourol. Urodynam. 26:1030–1035, 2007.  2007 Wiley-Liss, Inc.
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INTRODUCTION
Pelvic organ prolapse (POP) is a complex condition often
associated with both urinary incontinence and urinary
retention. The studies that address urodynamic evaluation
in women with POP have focused on uncovering urodynamic
stress incontinence during prolapse reduction1–5 or defining
obstructive voiding on pressure flow studies.6,7 Interpretation
of these studies has been limited by their small sample sizes.
To better understand bladder function in women with
prolapse, we conducted a prospective supplementary study to
the NIH/NICHD’s Pelvic Floor Disorders Network (PFDN)
Colpopexy and Urinary Reduction Efforts (CARE) study.8 The
CARE study enrolled women without symptoms of stress
incontinence undergoing sacrocolpopexy for pelvic organ
prolapse with the primary aim of determining if adding a
Burch urethropexy at the time of surgery would reduce
symptoms of stress incontinence 3 months post-operatively.
Since stress urinary incontinence (SUI) symptoms occur in 25–
100% of women with advanced prolapse,1,2,4–7 we recognized
the opportunity to compare women enrolled in CARE with
women who were also undergoing sacrocolpopexy for pro-
lapse but who additionally had stress incontinence symptoms.
By studying a large group of women with POP who are
similar except for their symptoms of stress incontinence, our
overall aim was to better understand how concomitant
urethral incompetence impacts patient symptoms and void-
ing parameters. Our hypothesis was that urethral incompe-
tence as indicated by stress incontinence symptoms may
modify the functional obstruction of pelvic organ prolapse.
The specific aims of this study were to compare voiding
parameters and correlate symptoms and urodynamic findings
in three groups of women with symptomatic pelvic organ
prolapse (POP) who were planning sacrocolpopexy and who
had varying degrees of urethral competence. We defined groups
as follows: Group 1 (no SUI), women with no stress urinary
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incontinence (SUI) symptoms and no urodynamic stress
incontinence (USI) during prolapse reduction; Group 2 (occult
SUI), women with no SUI symptoms who demonstrated USI on
reduction testing; Group 3 (overt SUI), women with SUI
symptoms.
METHODS
Urodynamic data for this study were obtained from
298 women with stages II–IV pelvic organ prolapse.9 Of these,
225 were planning sacrocolpopexy and represent the three
comparison groups; we enrolled an additional 73 women to
provide descriptive data only (see below). Groups 1 and 2
consist of women with no or minimal subjective symptoms of
stress urinary incontinence who participated in the Colpopexy
and Reduction Efforts Trial8 and underwent urodynamics
prior to surgery. Group 3, recruited specifically for this study,
consists of women with SUI symptoms who were planning to
undergo a sacrocolpopexy. Women in Group 3 met all the
inclusion/exclusion criteria for CARE except that they had
symptomatic SUI, an exclusion criterion for CARE. As noted,
we also enrolled an additional 73 women (Group 4) for
descriptive purposes only; these women had SUI symptoms
but were not planning to undergo sacrocolpopexy. Because
women with POP undergoing urodynamics who are not
planning abdominal surgery differ demographically from
our study groups, we decided a priori not to compare them
to the other three groups, but to describe them in order to add
to the scarce literature in this area.
We excluded women who were unable to provide informed
consent or participate in a quality of life telephone interview
in English, were currently pregnant or within 6 months
postpartum, had neurological diagnoses that may affect
voiding function such as multiple sclerosis or spinal cord
injury.
Patients were considered stress continent (and thus eligible
for CARE) if they responded ‘‘never’’ or ‘‘rarely’’ to six MESA10
stress incontinence questions: coughing hard, sneezing, lift-
ing, bending, laughing, and walking briskly or jogging8 and
stress incontinent if they responded ‘‘sometimes’’ or ‘‘usually’’
to any of these same MESA questions.
The make-up of the three comparative groups is summar-
ized as follows:
(1) Group 1 (no SUI): 67 women randomly selected from
women enrolled in the CARE study who had no subjective
symptoms of SUI on the MESA and demonstrated no USI
with prolapse reduction testing.
(2) Group 2 (occult SUI): 84 women randomly selected from
women enrolled in the CARE study who had no subjective
symptoms of SUI on the MESA, but who did demonstrate USI
with reduction testing (i.e., urinary leakage from the
urethral meatus with cough or valsalva).
(3) Group 3 (overt SUI): 74 women who were similar to CARE
patients, i.e., they were planning sacrocolpopexy for repair
of prolapse and they did have subjective symptoms of SUI
on the MESA.
Women enrolled in this supplementary study completed
questionnaires and procedures identical to those completed at
baseline in CARE. Relevant to this study were: demographic
and history questions, standardized pelvic organ prolapse
quantification11 examination by a certified research nurse,
standardized urodynamic evaluation (described in detail
below), and the pelvic floor distress inventory (PFDI).12 These
survey instruments were completed via a telephone interview
from the Quality of Life Interviewing Center at the University
of Michigan.
Lower urinary tract storage symptoms (urgency, frequency,
sensation) were obtained by positive responses and report of
at least moderate bother to the items in the urinary distress
inventory (UDI) of the PFDI12 (i.e., questions 17, 18, 19, 23, 26,
27, 29, 33, 34, 28). Voiding symptoms were obtained by
positive responses and report of at least moderate bother to
the items in the obstructive/discomfort scale of the UDI in
PFDI12 (i.e., questions 11, 12, 13, 14, 15, 16).
Urodynamics Protocol
Non-fluoroscopic urodynamic studies with external water
pressure transducers were performed on all participants
preoperatively. Uroflowmetry was done with participants in
a seated position with a comfortably full bladder before
urethral instrumentation. Post-void residual (PVR) urine
volume was obtained by catheterization within 15 min of
voiding. Urodynamics were rescheduled if dipstick urinalysis
suggested infection. The uroflowmeter was calibrated in
accordance with routine clinical practice standards and the
scale was set to zero before each study. We did not repeat the
uroflowmetry if the participant was unable to void or had a
voided volume <150 ml as the applicability of this minimum
voiding volume, in terms of study interpretation, is not known
for women with pelvic organ prolapse.
The cystometrogram was performed with participants
seated at a 45 angle using the same multichannel urody-
namic recorder as was used for the CARE protocol. External
water transducer catheters 8 French were used and zeroed to
atmosphere at the superior level of the symphysis pubis prior
to insertion. Intravesical pressure (Pves), intra-abdominal
pressure (Pabd), and subtracted detrusor pressure (Pdet)
were continuously recorded on a multichannel urodynamics
recorder throughout the cystometrogram. The bladder was
filled with saline or sterile water at 50 ml/min. A rectal
catheter was used to estimate intra-abdominal pressure. If the
detrusor pressure was not between 0 and 5 cm H2O during
early filling, the ports were flushed and the equipment was re-
zeroed. Baseline intravesical pressure was recorded at the start
of infusion. If a detrusor contraction occurred that caused a
large volume of leakage during bladder filling at a volume less
than 300 ml, the bladder was emptied and filling restarted at
an infusion rate half of the original rate (i.e., 25 ml/min).
At 300 ml or maximum bladder capacity, whichever was
lower, baseline intravesical pressure was recorded at rest.
Participants then did a series of three coughs and three
valsalva efforts, first with the prolapse out and then with each
of two methods of prolapse reduction. Details of the prolapse
reduction technique have been previously published.13 Briefly,
each site used two of five methods to reduce prolapse (hand,
speculum, pessary, cotton swab, and ring forceps). Each site
used the same two methods for the whole study. At 300 ml
bladder volume, the prolapse was reduced with the first and
then the second of two methods assigned to each clinical site.
At this point, the second prolapse reduction method was left
in place and the bladder was filled to maximum capacity. The
valsalva and cough sequences were repeated at maximum
capacity with only the second prolapse reduction method.
If the participant had not leaked following valsalva and
cough testing at maximum capacity, the transurethral
catheter was removed and the participant was instructed to
valsalva and cough with maximal effort. Any urine leakage
was recorded. Regardless of whether leakage occurred, the
prolapse reduction method was removed and the transure-
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thral catheter was replaced for the pressure flow voiding
study.
The prolapse was not reduced at the time of the pressure
flow study by the research staff and the patient was instructed
to bear down or cough to encourage the prolapse to become
maximal again prior to voiding. Urethral relaxation was not
documented during the pressure flow voiding study.
In accordance with recommendation of the ICS Stand-
ardization Committee of Good Urodynamic Practice,14 the
scaling of the tracings was standardized across centers as
follows: One millimeter was equal to 1 sec on the x-axis for
both flow and volume; and on the y-axis, 1 mm was equal to
1 ml/sec for flow and equal to 10 ml for volume. For the
cystometrogram and pressure flow signals, a minimum
scaling was set at 25 cm H2O/cm for pressure; 25 ml/sec/cm
for flow; and 1 min/3 cm for the time axis. The signals of the
non-instrumented uroflowmetry and pressure flow study
were clearly labeled to simplify a central review. The tracings
were annotated in accordance with the required data points.
Each urodynamic tracing including the non-instrumented
uroflow (NIF) and pressure flow study (PFS) were independ-
ently reviewed centrally by three PFDN investigators (IN, KK,
JW). The voiding pattern, derived independently from both the
NIF and the PFS, was classified based on the tracing as
continuous (flow rate reaches zero only at the end of void),
interrupted (flow rate diminishes to zero at least once prior to
end of void) or unable to determine. Voiding mechanism was
classified based on the PFS as detrusor (any increase in Pdet
during peak flow), strain (greater than or equal to 15 cm H2O
increase in Pabd during peak flow), detrusor and strain,
neither, or unable to determine (catheter fell out or significant
artifact). The individual interpretations of the three reviewers
were collated and where all three differed for any given data
element, the tracings were arbitrated with all three inves-
tigators present. During arbitration, the tracings were
reviewed and majority vote was required to arrive at final
determination for each data element.
Description of Variables
We assessed obstruction using the parameters of non-
instrumented maximum flow rate (Qmax NIF) and maximum
detrusor pressure (Pdetmax) from the pressure flow studies
as outlined by Blaivis–Groutz.15 The void was defined as
obstructed when values fell outside of the ‘‘unobstructed area’’
on the nomogram.
Urinary retention was defined as voiding <75% of total
bladder volume. Maximum bladder capacity was defined as
the volume at which women stated they could no longer delay
a trip to the bathroom.
Statistical Analysis
The three groups were compared by either a chi-square test
when the measure was discrete or by an analysis of variance
when the measure was continuous. Urodynamic data for the
three groups were also compared after adjustment for age as
a continuous measure and prior surgery for prolapse or
incontinence. Correlations were computed to assess associa-
tions between measures.
With approximately 70 subjects per group there is almost
80% power to identify a difference of 0.5SD when testing a
continuous outcome or a difference of 25% when testing a
dichotomous outcome at a 5% level of significance.
RESULTS
Demographic characteristics and physical exam findings of
the three groups, shown in Table I, were similar among
cohorts except women in Group II were older (P¼ 0.022) and
the proportion of women that had undergone previous incon-
tinence surgery differed between all three groups (P< 0.001).
Only 13.7% of women with pre-operative symptoms
demonstrated leakage during cough or valsalva testing with-
out reduction; however, when prolapse reduction was
performed in these same women, over two thirds (69.7%)
demonstrated leakage (Table II). Women without SUI symp-
toms and without USI on prolapse reduction (Group 1) were
less likely to have detrusor overactivity (DO) or detrusor
overactivity incontinence (DOI) on urodynamics than were
women with occult or overt SUI (6, 16.7, 23.6%, respectively for
DO; P¼ 0.016 and 0, 8.3, 15.3%, respectively for DOI; P¼ 0.004).
The median PVR for the three groups combined was 46 ml
based on catheterization after the NIF and 25 ml based on
Neurourology and Urodynamics DOI 10.1002/nau
TABLE I. Characteristics of Study Population
Characteristic: mean SD or n (%) No SUI (N¼ 67) Occult SUI (N¼ 84) Overt SUI (N¼ 74) P-value
Age 58.2  10.4 62.2  10.8 57.2  14.4 0.02a
Parity 2.8  1.3, median 2.0,
range 1–8
3.0  1.3, median 3.0,
range 1–7




Less than high school 6 (9.0%) 3 (3.6%) 7 (9.5%)
Completed high school or equivalent 26 (38.8%) 38 (45.2%) 22 (29.7%)
Some college/Associate degree 16 (23.9%) 26 (31.0%) 29 (39.2%)
Completed 4 years of college 9 (13.4%) 8 (9.5%) 7 (9.5%)
Graduate/Professional degree 10 (14.9%) 9 (10.7%) 9 (12.2%)
POP-Q stage 0.99
II 8 (11.9%) 11 (13.1%) 10 (13.5%)
III 48 (71.6%) 61 (72.6%) 54 (73.0%)
IV 11 (16.4%) 12 (14.3%) 10 (13.5%)
Prior surgery for POP 18 (26.9%) 35 (42.2%) 30 (41.1%) 0.11
Prior surgery for UI 0 (%) 8 (9.6%) 19 (25.7%) <0.001b
Maximum anterior prolapse (cm) þ3.0  2.5 þ3.2  2.6 þ2.8  2.8 0.72
Maximum posterior prolapse (cm) þ2.6  3.0 þ2.4  3.4 þ2.0  3.4 0.52
Maximum vaginal descent (cm) þ3.6  2.2 þ3.9  2.2 þ3.6  2.4 0.75
aWomen with occult SUI are older than either of the other two groups.
bAll three groups differ.
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calculation after the pressure flow study. Overall, 59.6% (102/
171) met the definition for obstruction. The median peak flow
for all groups combined was 14 ml/sec during the NIF and
17 ml/sec during the PFS. The median detrusor pressure at peak
flow was 25 cm H2O. The PVR, median peak flow rate, median
detrusor pressure at peak flow, rates of urinary retention, and
rates of obstruction were similar across the three groups
(Table II).
Of the 186 women for whom a voiding mechanism could be
determined, 118 (63.4%) voided by detrusor contraction alone,
51 (27.4%) voided with a combination of detrusor contraction
and strain, 4 voided by strain alone, and 13 voided with
neither strain nor detrusor contraction. We were unable to
determine the voiding mechanism in 39 (17.3%) women. There
were no differences in voiding mechanism or voiding pattern
by study group (Table II). There was no statistically significant
difference in the voiding mechanisms whether or not women
were obstructed, as defined by the nomogram.
We evaluated the association between urodynamic find-
ings and bladder symptoms as reported on the PFDI. While
women with overt SUI were more likely to have higher
irritative and obstructive symptom scores, neither the
irritative or obstructive symptom subscale score differed
according to whether urodynamics revealed DO or obstruc-
tion, respectively (Table III). There was a weak correlation
between the PVR from the pressure flow study and the UDI
obstructive subscale score (r ¼ 0.25).
DISCUSSION
This is the largest study to rigorously compare the uro-
dynamic findings of well-characterized women with advanced
pelvic organ prolapse with and without stress incontinence
symptoms. For decades, clinicians have assumed that
advanced POP and obstruction commonly coexist. If obstruc-
tion is an entity of importance in women, a cohort with POP is
the most logical clinical population to study.
The measure of obstruction in women (including women
with POP) was initially modeled on male obstruction,
although the entity of obstruction in women may be a
different clinical phenomenon than obstruction in men. Our
study highlights a high rate of obstruction, defined by one
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TABLE II. Urodynamic Findings
Characteristic: mean SD or N (%) No SUI (N¼ 67) Occult SUI (N¼ 84) Overt SUI (N¼ 74) P-value
USI without prolapse reduction 0 (%) 9 (11.0%) 10 (13.7%) 0.01
USI with prolapse reductiona 0 (%) 84 (100%) 46 (69.7%) <0.001
Detrusor overactivity on cystometrogram 4 (6.0%) 14 (16.7%) 17 (23.6%) 0.01
Detrusor overactivity incontinence on cystometrogram 0 (%) 7 (8.3%) 11 (15.3%) 0.02
Instrumented pressure flow study: voiding mechanism
Detrusor 35 (52.2%) 47 (56.0%) 36 (48.6%)
Strain 1 (1.5%) 0 (%) 3 (4.1%)
Detrusor and strain 23 (34.3%) 15 (17.9%) 13 (17.6%)
Neither 2 (3.0%) 5 (6.0%) 6 (8.1%)
Unable to determine or unable to void 6 (9.0%) 17 (20.2%) 16 (21.6%)
Instrumented pressure flow study: voiding pattern
Continuous 25 (37.3%) 33 (39.3%) 40 (54.1%)
Interrupted 38 (56.7%) 43 (51.2%) 29 (39.2%)
Unable to determine or unable to void 4 (6.0%) 8 (9.5%) 5 (6.8%)
Obstruction by nomogram 36 (65%) 42 (60%) 24 (49%) 0.23
Urinary retention on NIF (volume voided < 75% of bladder capacity) 36 (42.1%) 30 (38.0%) 23 (37.1%) 0.84
Urinary retention on PFS (volume voided < 75% of bladder capacity) 22 (32.8%) 21 (27.3%) 20 (29.9%) 0.77
Post-void residual volume (cm3) (non-instrumented
uroflowmetry)b (median)
80.7  95.7 (50.0) 76.5  101.5 (50.0) 67.1  72.6 (40.0) 0.67
Post-void residual volume (cm3) (pressure flow study) (median) 90.5  118.2 (33.0) 74.6  129.5 (25.0) 74.1  96.7 (30.0) 0.64
Maximum flow (median) 19.2  11.7 (18.0) 19.2  10.6 (18.0) 21.3  12.3 (17.0) 0.49
Detrusor pressure at maximum flow (median) 31.6 (24.8) (25.0) 30.3 (21.6) (26.0) 26.8 (22.1) (23.0) 0.46
aSignificant due to definition of cohorts.
bDerived from calculating maximum bladder capacity minus volume voided. When this difference was a negative number (N ¼ 92), the PVR was deemed
0 cm3.
TABLE III. Association Between Symptoms on the PFDI and Urodynamic Findings
Characteristic: mean SD (median) N No SUI Occult SUI Overt SUI P-value Adjusted P-valuea
Irritative subscale score (median)b
DO present 25.6  24 (18.8) 4 26.1  16.9 (32.5) 14 46.1  22.2 (47.5) 17 0.02c 0.05
DO absent 17.0  15.4 (15.0) 62 21.4  16.9 (18.8) 70 39.9  24.3 (37.5) 52 <0.001d <0.001
Obstructive subscale score (median)e
Obstruction present 32.0  18.4 (27.9) 36 44.5  22.8 (45.2) 42 45.2  28.5 (42.3) 24 0.03 0.05
Obstruction absent 34.0  19.8 (28.8) 18 34.6  21.4 (28.8) 28 49.5  20.2 (46.2) 23 0.02 0.06
aAdjusted for age (continuous) and prior surgery for prolapse or incontinence.
bIrritative subscale scores did not differ according to whether or not DO was present.
cMean score for overt SUI group is higher than score for no SUI group.
dScore for overt SUI group is higher than score for no SUI group and occult SUI group.
eObstructive subscale score did not differ according to whether or not obstruction (defined by the nomogram) was present.
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commonly used nomogram in women with POP, but this
finding did not correlate with symptoms, regardless of degree
of urethral competence.
The current ICS nomenclature does not provide terms for
urodynamic findings during testing of women with POP. The
storage phase term ‘‘urodynamic stress incontinence’’ does
not discriminate as to whether advanced prolapse is reduced
nor does it report preferred reduction techniques. Similarly,
there are no recommendations for uninstrumented and
instrumented voiding studies in women with prolapse. Aside
from these nomenclature limitations, the urodynamic finding
of ‘‘reduced’’ USI or ‘‘obstruction’’ are of uncertain clinical
significance.
Most clinicians would assume that a woman with a weaker
sphincter (as evidenced by her SUI symptoms) should have
fewer obstructive symptoms. Indeed, we had a priori hypothe-
sized that as the degree of urethral competence decreased
from no SUI to occult SUI to overt SUI that obstruction,
retention, irritative symptoms, and obstructive symptoms
would decrease, because of the potential pressure release
valve effect of the less competent urethra in the face of
obstruction from prolapse. However, there is no evidence to
support this widely held belief. Obstruction, as defined, is a
voiding phase entity as opposed to stress incontinence which
is a filling phase entity. Given that our findings did not, in fact,
support our hypothesis, it is likely that urethral sphincter
function during storage does not relate to sphincter function
during emptying, when the normal sphincter relaxes. This
would explain why maximum flow rates and detrusor
pressures at maximum flow rates do not differ between
women with and without stress incontinence regardless of
their prolapse status (Table IV).15,16
That women with SUI have more irritative and obstructive
symptoms than women without SUI may reflect a more
endstage process in the evolution of pelvic floor disorders.
Women with SUI were more likely to have had prior SUI
surgery. We did adjust for this in our analyses, but the
possibility remains that some dysfunction may have been
caused by operative factors, such as denervation. We also did
not measure urethral pressures in this study and so cannot
comment on the correlation between actual pressures and
symptoms.
Clinicians recommend treating elevated PVRs associated
with advanced prolapse by reducing the prolapse, either
with surgery or pessary, as this nearly universally returns
the PVR to the normal range.17 Given this, it is reasonable to
question what additional value can be gained from pressure
flow voiding studies for women who already plan treatment
of POP. Our evaluation examined whether voiding studies
played a role in discriminating which women have storage
phase abnormalities, such as stress incontinence to better
understand bladder function in women with advanced
prolapse. We did not find evidence to support nor recom-
mend use a voiding phase study to ‘‘triage’’ the stress
incontinence procedure. However, the value of a pressure
flow study in patients with advanced prolapse undergoing a
concurrent stress incontinence procedure remains unclear.
There would be clinical value to such a voiding study if it
were able to predict patients who develop retention post-
operatively. Our study was not designed to answer this
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TABLE IV. Characteristics of Women With Prolapse and SUI Symptoms That Were Not Planning Sacrocolpopexy
(n¼ 73)
Characteristic: mean  SD or N (%)
Age (years) 59.6  13.7





Prior surgery for POP 19 (26.0%)
Prior surgery for UI 16 (21.9%)
USI without reduction 11 (15.1%)
USI with prolapse reduced 54 (78.3%)
USI only at capacity with prolapse reduced and catheter removed 5 (29.4%)
DO 11 (15.3%)
DO incontinence 7 (9.7%)
Obstruction (by nomogram) 33 (57.9%)
Retention (on non-instrumented uroflowmetry) 26 (40.6%)
Peak flow (cm3/sec) 22.5  11.5




Detrusor and strain 16 (21.9%)
Neither 6 (8.2%)
Unable to determine 16 (21.9%)
Voiding pattern (pressure flow study)
Continuous 36 (49.3%)
Interrupted 30 (41.1%)
Unable to determine 7 (9.6%)
Irritative symptom subscale score
DO present 36.7  21.6
DO absent 28.1  22.4
Obstructive symptom subscale score
Obstruction present (by nomogram) 41.0  23.7
Obstruction absent 40.7  24.0
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question and the anti-incontinence procedure was limited to
Burch colposuspension that is generally associated with a
low rate of post-operative retention.18 Given the increase in
the use of mid-urethral mesh slings and the potentially
higher rate of post-operative urinary retention, future
studies are warranted to examine the value of uninstru-
mented uroflowmetry studies and pressure flow studies in
predicting post-operative urinary retention associated with
slings in patients undergoing surgery for advanced prolapse.
Our study is limited by the lack of a gold standard for
obstruction in women. It is possible that alternative measur-
ing techniques may be more useful than the ones selected in
this study. Our study population is limited to women with
advanced prolapse planning sacrocolpopexy so we cannot
comment on the findings of ‘‘obstruction’’ in women with
better vaginal support or other cause of obstruction, including
iatrogenic causes.
Strengths of our study include the large sample size, multi-
site recruitment, standardized urodynamics procedures with
independent secondary review of voiding studies, and use of
validated condition-specific instruments to assess symptoms.
If future research finds that voiding abnormalities, includ-
ing obstruction, are of clinical importance in women with POP,
the appropriate diagnostic tests require careful validation and
testing for clinical relevance.
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